With the Biden administration’s help, Big Pharma is set to pull in a big bath of young customers.
The U.S. Food and Drug Administration recently approved the Moderna COVID-19 vaccine for children ages 6 to 17. That makes that age group eligible for both Pfizer and Moderna’s jabs.
On Wednesday, an FDA committee moved closer to authorizing Moderna and Pfizer to provide vaccines for children under age 5, all the way down to 6 months old.
But Dr. Joseph Ladapo, Florida’s state surgeon general, continued his defense of dubious medical procedures for his state’s youngest residents.
Speaking to reporters in Tallahassee, Ladapo noted, “We’ve been very consistent in our message. I continue to be amazed at how it strikes people as being a radical message. It’s actually a very simple message.”
In the news: Florida Gov. DeSantis Quips About Elon Musk’s Backing, Welcomes “Support From African-Americans”
“And that message is,” he continued, “we expect to have good data, that the benefits outweigh the risks of any therapies or treatments before we recommend those therapies or treatments to Floridians.”
“That is not going to change. I don’t think that is particularly radical. I think it’s very sensible,” Ladapo continued.
“There have been a lot of unusual things,” he added, such as some “approvals” that “have bypassed scientific review committees,” as well as “a lot of unpredictable and, sort of, scientifically inexplicable decision-making on the part of the FDA, sometimes on the part of the CDC, during the pandemic.”
“From what I have seen, there is just insufficient data to inform benefits and risks in children. I think that’s very unequivocal,” Ladapo said. “When you talk about older people, the risks are much more pronounced.”
This is the second major health issue recently that Ladapo, who doubles as secretary of the Florida Department of Health, has argued for protecting children.
In April, he came out against transition procedures for children who supposedly suffer from gender dysphoria.
In the news: Lightning Battle Back Before Falling In Overtime
Ladapo issued new guidelines saying puberty blockers, hormone therapy and gender reassignment surgery should all be rejected as treatments for Floridians under 18.
He cited reviews on hormonal treatment for that demographic that “show a trend of low-quality evidence, small sample sizes, and medium to high risk of bias.” He also pointed to studies that indicate 80 percent of children grow out of such a condition by the time they reach adulthood.
“Children experiencing gender dysphoria should be supported by family and seek counseling, not pushed into an irreversible decision before they reach 18,” Ladapo said at the time.
Earlier this month, Ladapo asked the state Board of Medicine to set guidelines on such treatments, saying “the scientific evidence supporting these complex medical interventions is extraordinarily weak.”